Development
Antiaging Quantum Living Inc.
AAQL
$0.60
-$0.40-40.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -41.22% | -47.54% | 55.00% | 83.78% | 117.65% |
| Total Other Revenue | -- | -- | -- | -- | -164.00% |
| Total Revenue | -34.09% | -39.62% | 93.75% | 102.99% | 53.49% |
| Cost of Revenue | -- | -- | -- | -- | -100.00% |
| Gross Profit | -40.15% | -36.63% | 133.96% | 142.86% | 76.00% |
| SG&A Expenses | 247.18% | 30.02% | -1.71% | -2.14% | -12.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 248.85% | 28.89% | -3.52% | -4.20% | -14.16% |
| Operating Income | -357.80% | -44.59% | 15.04% | 19.74% | 26.69% |
| Income Before Tax | -378.55% | -49.34% | 11.37% | 15.67% | 28.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -378.55% | -49.34% | 11.37% | 15.67% | 28.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -378.55% | -49.34% | 11.37% | 15.67% | 28.82% |
| EBIT | -357.80% | -44.59% | 15.04% | 19.74% | 26.69% |
| EBITDA | -360.93% | -44.56% | 15.44% | -13.08% | -27.51% |
| EPS Basic | -372.73% | -46.67% | 6.25% | 14.29% | 26.67% |
| Normalized Basic EPS | -450.00% | -55.56% | 10.00% | 22.22% | 33.33% |
| EPS Diluted | -372.73% | -46.67% | 6.25% | 14.29% | 26.67% |
| Normalized Diluted EPS | -450.00% | -55.56% | 10.00% | 22.22% | 33.33% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |